This inventor holds 1 USPTO granted patent. Top assignees: Baxter Healthcare Sa, Baxter International Inc.. Active years: 2015.
Company Filing History:
1 out of 1,198 
1 out of 2,530 
Years Active: 2015
Title: Maria Sasgary - Innovator in Transgenic Animal Research
Introduction
Maria Sasgary is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of biotechnology, particularly in the development of transgenic non-human animals. Her work focuses on expressing human blood clotting factors, which has important implications for medical research and treatment.
Latest Patents
Maria Sasgary holds a patent titled "Transgenic non-human animals expressing human blood clotting factors and uses thereof." This invention relates to the development of non-human transgenic animals that express human blood clotting factors, such as Factor VIII, Factor VII, Factor IX, and von Willebrand factor. The patent also provides methods for detecting immunogenic events against these human blood clotting factors using the described transgenic animals. She has 1 patent to her name.
Career Highlights
Throughout her career, Maria has worked with notable companies in the biotechnology sector, including Baxter International Inc. and Baxter Healthcare S.A. Her experience in these organizations has allowed her to advance her research and contribute to innovative solutions in healthcare.
Collaborations
Maria has collaborated with esteemed colleagues in her field, including Maria Schuster and Hans-Peter Schwarz. These partnerships have fostered a collaborative environment that enhances the research and development of transgenic technologies.
Conclusion
Maria Sasgary is a trailblazer in the field of transgenic animal research, with a focus on human blood clotting factors. Her innovative work and collaborations continue to pave the way for advancements in biotechnology and medical treatments.